tiprankstipranks
Advertisement
Advertisement

PMN Stock Latest News

ProMIS Neurosciences price target lowered to $29 from $30 at Roth Capital
The FlyProMIS Neurosciences price target lowered to $29 from $30 at Roth Capital
5d ago
PMN
BIIB
ProMIS Neurosciences reports Q2 EPS ($1.28), consensus ($1.90)
PremiumThe Fly
ProMIS Neurosciences reports Q2 EPS ($1.28), consensus ($1.90)
9d ago
PMN
ProMIS Neurosciences price target raised to $100 from $69 at Guggenheim
PremiumThe Fly
ProMIS Neurosciences price target raised to $100 from $69 at Guggenheim
10d ago
PMN
Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress
PremiumRatings
Analyst Reiterates Buy on ProMIS Neurosciences, Maintaining $35 Price Target Amid Strong Cash Position and PMN310 Clinical Progress
10d ago
PMN
PMN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PMN Earnings this Week: How Will it Perform?
15d ago
PMN
PMN310’s Clean Safety and Promising Biomarkers Drive Buy Rating; $35 Price Target Reiterated
PremiumRatingsPMN310’s Clean Safety and Promising Biomarkers Drive Buy Rating; $35 Price Target Reiterated
27d ago
PMN
ProMIS Neurosciences price target raised to $69 from $35 at Guggenheim
Premium
The Fly
ProMIS Neurosciences price target raised to $69 from $35 at Guggenheim
28d ago
PMN
ProMIS Neurosciences price target raised to $33 from $20 at Chardan
Premium
The Fly
ProMIS Neurosciences price target raised to $33 from $20 at Chardan
28d ago
PMN
ProMIS Neurosciences price target raised to $69 from $35 at Guggenheim
PremiumThe Fly
ProMIS Neurosciences price target raised to $69 from $35 at Guggenheim
29d ago
PMN
ProMIS Reports Positive Interim PMN310 Alzheimer’s Trial Data
PremiumCompany Announcements
ProMIS Reports Positive Interim PMN310 Alzheimer’s Trial Data
29d ago
8K
PMN
ProMIS Neurosciences’ PMN310 shows positive result in Alzheimer’s Phase 1b trial
PremiumThe Fly
ProMIS Neurosciences’ PMN310 shows positive result in Alzheimer’s Phase 1b trial
29d ago
PMN
ProMIS Neurosciences initiated with a Buy at Chardan
PremiumThe Fly
ProMIS Neurosciences initiated with a Buy at Chardan
30d ago
PMN
Buy Rating Reiterated on PMN310’s Promising Phase 1a Data and Unchanged $18 Price Target
PremiumRatingsBuy Rating Reiterated on PMN310’s Promising Phase 1a Data and Unchanged $18 Price Target
1M ago
PMN
ProMIS Neurosciences reports amyloid-beta oligomer reduction by PMN310
Premium
The Fly
ProMIS Neurosciences reports amyloid-beta oligomer reduction by PMN310
1M ago
PMN
ProMIS Neurosciences initiated with a Buy at Roth Capital
Premium
The Fly
ProMIS Neurosciences initiated with a Buy at Roth Capital
2M ago
PMN
ProMIS Neurosciences initiated with a Buy at Roth Capital
PremiumThe Fly
ProMIS Neurosciences initiated with a Buy at Roth Capital
2M ago
PMN
ProMIS Neurosciences initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
ProMIS Neurosciences initiated with an Overweight at Cantor Fitzgerald
2M ago
PMN
Analyst Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target on Differentiated Alzheimer’s Candidate PMN310
PremiumRatings
Analyst Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target on Differentiated Alzheimer’s Candidate PMN310
2M ago
PMN
Ram Selvaraju Reiterates Buy on ProMIS Neurosciences, Maintains $18 12-Month Price Target on Differentiated PMN310 Alzheimer’s Profile
PremiumRatings
Ram Selvaraju Reiterates Buy on ProMIS Neurosciences, Maintains $18 12-Month Price Target on Differentiated PMN310 Alzheimer’s Profile
3M ago
PMN
ProMIS Neurosciences shareholders approve directors and incentive plan
PremiumCompany AnnouncementsProMIS Neurosciences shareholders approve directors and incentive plan
3M ago
8K
PMN
ProMIS Neurosciences initiated with a Buy at Brookline
Premium
The Fly
ProMIS Neurosciences initiated with a Buy at Brookline
3M ago
PMN
ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year
Premium
The Fly
ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year
4M ago
PMN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >